News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
862,056 Results
Type
Article (87504)
Company Profile (807)
Press Release (773723)
Multimedia
Podcasts (177)
Webinars (28)
Section
Business (233083)
Career Advice (4140)
Deals (39803)
Drug Delivery (139)
Drug Development (91273)
Employer Resources (203)
FDA (18293)
Job Trends (17406)
News (397461)
Policy (39927)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (127)
Alliances (56980)
ALS (147)
Alzheimer's disease (1689)
Antibody-drug conjugate (ADC) (259)
Approvals (18326)
Artificial intelligence (506)
Autoimmune disease (98)
Automation (29)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (165)
Biotechnology (485)
Bladder cancer (137)
Brain cancer (53)
Breast cancer (516)
Cancer (4088)
Cardiovascular disease (355)
Career advice (3561)
Career pathing (38)
CAR-T (252)
CDC (57)
Cell therapy (700)
Cervical cancer (33)
Clinical research (75708)
Collaboration (1431)
Company closure (4)
Compensation (943)
Complete response letters (61)
COVID-19 (2961)
CRISPR (84)
C-suite (610)
Cystic fibrosis (140)
Data (4756)
Decentralized trials (2)
Denatured (64)
Depression (112)
Diabetes (459)
Diagnostics (7101)
Digital health (37)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (241)
Drug pricing (193)
Drug shortages (36)
Duchenne muscular dystrophy (205)
Earnings (99022)
Editorial (54)
Employer branding (25)
Employer resources (172)
Events (133240)
Executive appointments (996)
FDA (20843)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1292)
Gene editing (177)
Generative AI (52)
Gene therapy (560)
GLP-1 (1030)
Government (5391)
Grass and pollen (7)
Guidances (366)
Healthcare (20938)
HIV (48)
Huntington's disease (40)
IgA nephropathy (64)
Immunology and inflammation (248)
Immuno-oncology (22)
Indications (58)
Infectious disease (3210)
Inflammatory bowel disease (191)
Inflation Reduction Act (16)
Influenza (102)
Intellectual property (196)
Interviews (816)
IPO (17930)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (81)
Layoffs (643)
Leadership (36)
Legal (10148)
Liver cancer (92)
Longevity (13)
Lung cancer (585)
Lymphoma (269)
Machine learning (32)
Management (66)
Manufacturing (662)
MASH (145)
Medical device (14899)
Medtech (14924)
Mergers & acquisitions (22772)
Metabolic disorders (1178)
Multiple sclerosis (139)
NASH (23)
Neurodegenerative disease (234)
Neuropsychiatric disorders (63)
Neuroscience (2748)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (60)
Obesity (569)
Opinion (315)
Ovarian cancer (139)
Pain (170)
Pancreatic cancer (176)
Parkinson's disease (244)
Partnered (31)
Patents (427)
Patient recruitment (329)
Peanut (57)
People (66320)
Pharmaceutical (145)
Pharmacy benefit managers (28)
Phase I (23351)
Phase II (32849)
Phase III (24776)
Pipeline (2797)
Policy (300)
Postmarket research (3554)
Preclinical (10537)
Press Release (72)
Prostate cancer (204)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (694)
Real estate (7422)
Recruiting (79)
Regulatory (28097)
Reports (65)
Research institute (2694)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (76)
Schizophrenia (140)
Series A (213)
Series B (159)
Service/supplier (30)
Sickle cell disease (81)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (41)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (102)
Tariffs (96)
The Weekly (111)
Vaccines (1059)
Venture capital (67)
Weight loss (401)
Women's health (60)
Worklife (21)
Date
Today (141)
Last 7 days (746)
Last 30 days (2922)
Last 365 days (33491)
2025 (27592)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1282)
Alabama (80)
Alaska (7)
Arizona (307)
Arkansas (14)
Asia (51041)
Australia (8972)
California (9693)
Canada (2909)
China (933)
Colorado (409)
Connecticut (432)
Delaware (278)
Europe (117275)
Florida (1427)
Georgia (320)
Hawaii (3)
Idaho (67)
Illinois (822)
India (55)
Indiana (480)
Iowa (20)
Japan (331)
Kansas (126)
Kentucky (39)
Louisiana (22)
Maine (78)
Maryland (1299)
Massachusetts (7257)
Michigan (317)
Minnesota (575)
Mississippi (4)
Missouri (123)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (80)
New Jersey (2694)
New Mexico (32)
New York (2628)
North Carolina (1427)
North Dakota (10)
Northern California (4426)
Ohio (306)
Oklahoma (22)
Oregon (51)
Pennsylvania (2015)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (50)
South Dakota (1)
Southern California (3699)
Tennessee (152)
Texas (1527)
United States (35732)
Utah (289)
Virginia (251)
Washington D.C. (84)
Washington State (833)
West Virginia (4)
Wisconsin (98)
Wyoming (1)
There are 862,056 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SpectronRx Begins Commercial-Scale Production of High-Purity Actinium-225, Strengthening Global Supply for Cancer Therapies
Indiana-based radiopharmaceutical contract development and manufacturing organization producing Ac-225 at a scale
October 30, 2025
·
1 min read
Press Releases
Hemostemix’s Boots on the Ground in Florida October Update
October 30, 2025
·
9 min read
Earnings
Merck Vaccine Sales Drop as US Declines Strike Another Pharma
While the company’s sales outlook was otherwise rosy, Merck took sales hits on Gardisil, Proquad, Varivax and Vaxneuvance.
October 30, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
PharmaDrug Signs Definitive Agreement to Acquire Equity Interest in Canurta Inc
October 30, 2025
·
8 min read
Layoff Tracker
Sensei Plans to Cut Workforce While Considering Strategic Alternatives
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
October 30, 2025
·
76 min read
·
BioSpace Editorial Staff
Press Releases
BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis
Partnership with “Saffron Tech” to Advance Production of One of the World’s Most Valuable Botanicals Management Concurrently Shares Third Quarter 2025 Preliminary Results and Provides Guidance for the Fourth Quarter of 2025
October 30, 2025
·
10 min read
Press Releases
PreveCeutical Closes Second Tranche of Non-Brokered Private Placement
October 30, 2025
·
5 min read
Press Releases
Quantum BioPharma Ltd. Announces Corporate Updates
October 30, 2025
·
11 min read
Press Releases
Model Medicines to Present 325 Billion Molecule Throughput Oncology Screen, at Google Cloud’s Cancer AI Symposium
At Google Cloud’s second annual Cancer AI Symposium, Model Medicines will unveil how its GALILEO™ platform, built on Google Cloud, powered a 325 billion molecule throughput oncology screen — the largest of its kind — opening the door to trillion‑scale discovery and culminating in the discovery of MDL‑4102, a potent and selective BRD4 inhibitor.
October 30, 2025
·
1 min read
Earnings
BMS Battles ‘Deeply Ingrained’ Prescribing Habits in Schizophrenia as Cobenfy Misses Q3 Estimates
Bristol Myers Squibb beat analyst and consensus estimates for the third quarter with $12.2 billion in sales, but executives on the company’s investor call faced questions about a sluggish uptake for schizophrenia drug Cobenfy as well as a highly anticipated Alzheimer’s psychosis readout for the product.
October 30, 2025
·
3 min read
·
Heather McKenzie
1 of 86,206
Next
